Swisscanto (LU) Equity Fund Sustainable Healthy Longevity NT

Reference Data

ISIN LU2851594825
Valor Number 136503267
Bloomberg Global ID
Fund Name Swisscanto (LU) Equity Fund Sustainable Healthy Longevity NT
Fund Provider Swisscanto Fondsleitung AG Zurich
E-Mail: fonds@swisscanto.ch
Fund Provider Swisscanto Fondsleitung AG
Representative in Switzerland Swisscanto Fondsleitung AG
Distributor(s) Schweizerische Kantonalbanken
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The total commitments of the fund may not amount to more than 210% as a result of the use of derivatives (max. 100%) and temporary borrowing (max. 10%).
Peculiarities

Fund Prices

Current Price * 92.21 EUR 21.08.2025
Previous Price * 92.40 EUR 20.08.2025
52 Week High * 104.93 EUR 30.01.2025
52 Week Low * 88.70 EUR 08.04.2025
NAV * 92.21 EUR 21.08.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 82,014,777
Unit/Share Assets *** 4,075,530
Trading Information SIX

Performance

YTD Performance -7.00% 31.12.2024
21.08.2025
YTD Performance (in CHF) -7.17% 31.12.2024
21.08.2025
1 month +3.27% 21.07.2025
21.08.2025
3 months -0.28% 21.05.2025
21.08.2025
6 months -9.61% 21.02.2025
21.08.2025
1 year -7.79% 27.08.2024
21.08.2025
2 years - -
3 years - -
5 years - -

Tax Data

Equity Participation Rate in % 90.38
Share of Total Fund Assets in %
Real Estate Rate in % 0.00
ADDI
ADDI Date

Top 10 Holdings ***

Fresenius SE & Co KGaA 3.78%
Eli Lilly and Co 3.78%
Edwards Lifesciences Corp 3.09%
Lonza Group Ltd 3.04%
AstraZeneca PLC 2.69%
Welltower Inc 2.69%
Essilorluxottica 2.61%
Hoya Corp 2.53%
Incyte Corp 2.48%
Amgen Inc 2.44%
Last data update 31.07.2025

Cost / Risk

TER 0.01%
TER date 31.03.2025
Performance Fee ***
PTR
Max. Management Fee *** 0.00%
Ongoing Charges *** 0.01%
SRRI ***
SRRI date *** 31.07.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)